by Sabrina | Mar 18, 2024 | Uncategorized
Eolo Pharma, the drug design and development company founded and driven by researchers and entrepreneurs from the Institut Pasteur de Montevideo (IP Montevideo) and the University of the Republic (Udelar), obtained approval to initiate the first human clinical trial...
by Sabrina | Feb 28, 2024 | News
LAB+ presented this Thursday the closing of its first round of capitalization and the first four start-ups that will be financed with this fund. Each will receive US$ 750,000 for a two-year term. The objective of LAB+ is to support scientists with disruptive ideas in...
by Sabrina | Dec 26, 2023 | News
For the first time, the Institut Pasteur de Montevideo became a partner of a biotech start-up -Xeptiva Therapeutics-, a new business model that the institute has been promoting through its Lab+ initiative. The agreement – which is a historic milestone for both parties...
by Sabrina | Oct 20, 2023 | News
The Institut Pasteur de Montevideo hosted the second edition of the Uruguay Innovation Forum, a national initiative that brings together several institutions that seek to disseminate innovation activities. This second edition was entitled “Disruptive Innovation in...
by Sabrina | Dec 1, 2022 | Closed calls
LAB+ Venture Builder, an initiative promoted by the Institut Pasteur de Montevideo with the financial and know-how contribution of the investment banking firm FICUS Advisory, is now launching an international call to bring together in 2023 research & innovator...
Recent Comments